Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Cgm in Korea, Democratic People's Republic of
Total 1 results
Pfizer
Recruiting
Korean Post-marketing Surveillance Vyndamax® Capsules for the Treatment of Transthyretin Amyloid Cardiomyopathy
ATTR-CM (Transthyretin Amyloid Cardiomyopathy)
Korea, Republic of
Sponsors and Collaborators
Deutsche Arthrose-Hilfe
University of Natural Resources and Life Sciences, Vienna, Austria
The First Affiliated Hospital of Air Force Medicial University
Faculdade de Medicina da Universidade do Porto (FMUP)
RINO ZUID
Centre Hospitalier de Bastia
Cooperative Clinical Drug Research and Development AG (CCDRD AG)
InfraScan, Inc.
Prof. Jürgen Kuschyk, M.D
Research Unit of General Practice, Odense
Institute of Antibiotics, Huashan Hospital, Fudan University
Canadian Hemophilia Society
Delosis Limited
Alfred Hospital Intensive Care Unit Australia
Jiajie Chen
Stefania Basili
IDRI Corporation
Jikei University School of Medicine
Donna Hammond, PhD
Shamir Optical Industry Ltd
View Full List
Medical Conditions
Pharyngitis, Infective
Pathological Fracture, Right Femur
Febrile
Pneumonectomy; Status
Gait, Spastic
Pancreatobiliary Disease
Diarrheal Disease, Infectious
The Coagulolytic Balance
Homocystinuria Due to Cystathionine Beta-Synthase Deficiency
Pulmonary Arteriovenous Malformations
BK Viremia
Cancer Survivor With History of Anthracycline Chemotherapy
Trauma Dental
CaIMR
Inotropic Agents
Stage IVA Laryngeal Verrucous Carcinoma
Sickle Cell Ulcer
Therapy-Related MDS
Chronic Pruritus of Unknown Origin
Respiratory Distress Syndrome, Pediatric
View Full List
Drug Interventions
HLX23
Sorafenib and OSI-906
Propranolol Hydrochloride Extended Release Capsules 160 mg
LIS 18 U
Moxifloxacin
Nanoliposomal Irinotecan
13 valent pneumococcal conjugate vaccine and 23 valent pneumococcal polysaccharide vaccine
Arm 1 - GEH120714 (18F) Injection
Epoetin beta (NeoRecormon®)
Prucalopride
Rosuvastatin calcium tablets
Radioligand (11C)AZD2184
Domperidone
PF regimen (cis-platinum ; 5-fluorouracil ) combined with PD-1 inhibitors(pembrolizumab)
Chlorcyclizine HCl
INCB7839
Hypertonic saline
Atorvastatin, 10mg, 20mg, 40mg
Gemcitabine (mg/m²)
JR-141
View Full List
CROs by country
Contract Research Organizations in Austria
Contract Research Organizations in Belarus
Contract Research Organizations in China
Contract Research Organizations in Djibouti
Contract Research Organizations in Jamaica
Contract Research Organizations in Mauritania
Contract Research Organizations in Mongolia
Contract Research Organizations in Myanmar
Contract Research Organizations in New Zealand
Contract Research Organizations in Panama
Contract Research Organizations in Papua New Guinea
Contract Research Organizations in Suriname
Contract Research Organizations in Zambia
CRO list by country
CROs in Ethiopia
SGS
All CROs in Ethiopia
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe